Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,056 signal articles · 234 in last 24h · 119,523 total before filter · latest 52m ago
234last 24h
1477last 7d
249● bullish (7d)
157● bearish (7d)
205publishers
AllMacro283Earnings568M&A106Regulatory20Product13Analyst22
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
What Southern Copper (SCCO)'s Record Q2 Dividend and Earnings Amid Lower Output Means For Shareholders
Simply Wall St.15d agoneutral
What Southern Copper (SCCO)'s Record Q2 Dividend and Earnings Amid Lower Output Means For Shareholders

Southern Copper Corporation previously declared a US$1.10 per-share cash dividend for the second quarter of 2026, payable on August 27 to shareholders of record as of August 11, while also reporting year-on-year declines in mined volumes for copper, molybdenum, zinc and silver. Even with lower production, the company delivered record-breaking quarterly results as historically strong metal prices more than offset the volume declines. Next, we’ll examine how record financial results driven by...

SpaceX revenue jumps 92% in first earnings report
AFP15d agobullish
SpaceX revenue jumps 92% in first earnings report

SpaceX's revenue jumped 92 percent in the second quarter, beating analyst expectations by around $1 billion in its first earnings report since going public in June, the company announced Tuesday.Investors remain skeptical even with SpaceX beating expectations, Emarketer Senior Analyst Gadjo Sevilla told AFP.  "I don't think people want to hear promises about the next five years or a mission to Mars," Sevilla said. 

Gilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026
StockStory15d agobullish
Gilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.2% year on year to $7.80 billion. On the other hand, the company’s full-year revenue guidance of $30.25 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP loss of $6.75 per share was 6.9% above analysts’ consensus estimates.

Caterpillar Q2 Earnings Call Highlights
MarketBeat15d agoneutral
Caterpillar Q2 Earnings Call Highlights

Caterpillar (NYSE:CAT) reported record second-quarter sales and revenues of $20.5 billion, up 24% from a year earlier, as demand increased across its Construction Industries, Resource Industries and Power & Energy segments. The company said it was the first quarter in its history with more than